Zwitterionic Copolymer Coating for Biomolecule Resistance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional antimicrobial agents, such as heavy metals and toxins, are harmful to humans and the environment, and may not effectively kill microbes, leading to the development of resistant 'superbugs', while existing nanotechnology solutions may not be suitable for all medical applications.
Innovation Solution
Development of surface anti-biomolecule agents comprising biomolecule resistance block, random, or copolymers with zwitterionic and anchoring blocks or domains that bind to charged substrates via electrostatic forces, reducing microbial attachment through zwitterionic blocks extending outwardly, and potentially detach with an external electric field for smart coating applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antimicrobial agents (heavy metals, poisons, antibiotics) are used to control microorganisms, then microbial growth is inhibited or killed, but harmful effects to humans, treated surfaces, and environment occur, and microbial resistance develops
Solution Approach 1:
The invention changes the fundamental parameter of antimicrobial mechanism from chemical toxicity to physical electrostatic interaction. The copolymer uses charged blocks that bind to charged substrates via electrostatic forces, creating a non-toxic physical barrier that prevents microbial attachment without relying on harmful chemical agents
Solution Approach 2:
The invention employs a composite copolymer structure combining charged blocks (for substrate binding) and zwitterionic blocks (for microbial resistance). This composite material integrates multiple functional blocks into a single molecule, achieving both strong substrate attachment and effective antimicrobial protection without harmful effects
2Reliability
If antimicrobial nanotechnology is used to provide mechanical kill effect, then microbial resistance is prevented and long-lasting protection is achieved, but applicability to medical applications is limited
Solution Approach 1:
The invention transitions from nanoscale physical mechanisms to molecular-scale electrostatic interactions. By using charged blocks that bind to charged substrates through electrostatic forces, the system achieves both long-lasting protection and broad medical applicability, as electrostatic interactions are fundamental and universally applicable across different medical contexts
3Reliability
If zwitterionic blocks extend outwardly to reduce biomolecule attachment, then biomolecule resistance is achieved, but the complexity of copolymer structure increases
Solution Approach 1:
The invention divides the copolymer into distinct functional blocks: charged blocks for substrate binding and zwitterionic blocks for microbial resistance. This segmentation allows each block to perform its specific function independently, simplifying the design and synthesis process while achieving complex multifunctional performance
Solution Approach 2:
The charged blocks serve multiple functions: they bind to charged substrates to anchor the copolymer and create a structured arrangement of zwitterionic blocks. This multi-functionality reduces overall system complexity by combining attachment and organizational roles in a single block type
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides safe, long-lasting, and environmentally friendly antimicrobial barriers effective against a wide range of microbial contaminants on various substrates, including medical and industrial surfaces, without the risks associated with traditional agents.
Implementation Method 1
the sub-block having the first electricity binds to sites, on the charged surfaces, having a second electricity opposite to the first electricity
Implementation Method 2
the zwitterionic block extends outwardly to reduce the attachment of biomolecules to the charged substrate
Data Source
AI summary
This invention discloses a surface anti-biomolecule agent for an artificially or naturally charged substrate. The anti-biomolecule agent comprises a copolymer employing anchoring blocks or domains to binds sites of the substrate via electrostatic attractive force, and employing zwitterionic blocks or domains extended outwardly to reduce the attachment of biomolecules to the substrate.